Randomized controlled trials: Often flawed, mostly useless, clearly indispensable: A commentary on Deaton and Cartwright

John P A Ioannidis

doi:10.1016/j.socscimed.2018.04.029

Back

Randomized controlled trials: Often flawed, mostly useless, clearly indispensable: A commentary on Deaton and Cartwright

Letter 2018 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Letter1998

Meta-Analyses and Large Randomized, Controlled Trials

John P A Ioannidis, Joseph C. Cappelleri, Joseph T. F. Lau

Article2015

Head-to-head randomized trials are mostly industry sponsored and almost always favor the industry sponsor

Maria Elena Flacco, Lamberto Manzoli, Stefania Boccia, Lorenzo Capasso, Katina Aleksovska, Annalisa Rosso, Giacomo Scaioli, Corrado De Vito, Roberta Siliquini, Paolo Villari, John P A Ioannidis

Letter2004

Registering CIHR-funded randomized controlled trials: a global public good

David Moher

Article1995

Meta-analysis of randomized controlled trials. A concern for standards;

David Moher

Article1995

Meta-analysis of randomized controlled trials. A concern for standards;.

David Moher, Ingram Olkin